Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Luque

Showing results (351-360 of 364) with videos related to

Pageof 37
Sort By:
Materials (Basel, Switzerland)|May 5, 2019
Bentonites Modified with Phosphomolybdic Heteropolyacid (HPMo) for Biowaste to Biofuel ProductionAlex de Nazaré de Oliveira, Marco Aurélio Barbosa de Lima, Luíza Helena de Oliveira Pires, et al.
Scientific Reports|November 8, 2024
An ultra-short-period super-Earth with an extremely high density and an outer companionJohn H Livingston, Davide Gandolfi, Alessandro A Trani, et al.
Infectious Diseases (London, England)|May 26, 2021
Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort studyLorenzo Roberto Suardi, Arístides de Alarcón, María Victoria García, et al.
Journal of Clinical Medicine|March 6, 2021
Clinical Factors Associated with Reinfection versus Relapse in Infective Endocarditis: Prospective Cohort StudyJorge Calderón-Parra, Martha Kestler, Antonio Ramos-Martínez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2019
Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: A Prospective Cohort Study From the GAMES CohortJuan M Pericà S, Jaume Llopis, Víctor González-Ramallo, et al.
Journal of Clinical Medicine|January 11, 2022
Ampicillin Plus Ceftriaxone Combined Therapy for <i>Enterococcus faecalis</i> Infective Endocarditis in OPATLaura Herrera-Hidalgo, Jose Manuel Lomas-Cabezas, Luis Eduardo López-Cortés, et al.
Pharmaceutics|November 27, 2025
Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat CareSantiago J Lora-Escobar, Laura Herrera-Hidalgo, Nerea Castillo-Fernández, et al.
Pharmaceutics|May 27, 2026
Outpatient Parenteral Antimicrobial Therapy for <i>Pseudomonas aeruginosa</i> Infections: Effectiveness and SafetyPaloma Suárez-Casillas, Marta Mejías-Trueba, Iris Martínez Alemany, et al.
Open Forum Infectious Diseases|June 30, 2021
Clinical Features and Outcomes of <i>Streptococcus anginosus</i> Group Infective Endocarditis: A Multicenter Matched Cohort StudyFrancesc Escrihuela-Vidal, Luis Eduardo López-Cortés, Laura Escolà-Vergé, et al.
BMJ Open Respiratory Research|December 8, 2025
Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocolLaura Diab Casares, Juan Espinosa Pereiro, María Teresa Tórtola Fernández, et al.
Pageof 37

Showing results (351-360 of 364) with videos related to

Sort By:
Pageof 37
Materials (Basel, Switzerland)|May 5, 2019
Bentonites Modified with Phosphomolybdic Heteropolyacid (HPMo) for Biowaste to Biofuel ProductionAlex de Nazaré de Oliveira, Marco Aurélio Barbosa de Lima, Luíza Helena de Oliveira Pires, et al.
Scientific Reports|November 8, 2024
An ultra-short-period super-Earth with an extremely high density and an outer companionJohn H Livingston, Davide Gandolfi, Alessandro A Trani, et al.
Infectious Diseases (London, England)|May 26, 2021
Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort studyLorenzo Roberto Suardi, Arístides de Alarcón, María Victoria García, et al.
Journal of Clinical Medicine|March 6, 2021
Clinical Factors Associated with Reinfection versus Relapse in Infective Endocarditis: Prospective Cohort StudyJorge Calderón-Parra, Martha Kestler, Antonio Ramos-Martínez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2019
Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: A Prospective Cohort Study From the GAMES CohortJuan M Pericà S, Jaume Llopis, Víctor González-Ramallo, et al.
Journal of Clinical Medicine|January 11, 2022
Ampicillin Plus Ceftriaxone Combined Therapy for <i>Enterococcus faecalis</i> Infective Endocarditis in OPATLaura Herrera-Hidalgo, Jose Manuel Lomas-Cabezas, Luis Eduardo López-Cortés, et al.
Pharmaceutics|November 27, 2025
Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat CareSantiago J Lora-Escobar, Laura Herrera-Hidalgo, Nerea Castillo-Fernández, et al.
Pharmaceutics|May 27, 2026
Outpatient Parenteral Antimicrobial Therapy for <i>Pseudomonas aeruginosa</i> Infections: Effectiveness and SafetyPaloma Suárez-Casillas, Marta Mejías-Trueba, Iris Martínez Alemany, et al.
Open Forum Infectious Diseases|June 30, 2021
Clinical Features and Outcomes of <i>Streptococcus anginosus</i> Group Infective Endocarditis: A Multicenter Matched Cohort StudyFrancesc Escrihuela-Vidal, Luis Eduardo López-Cortés, Laura Escolà-Vergé, et al.
BMJ Open Respiratory Research|December 8, 2025
Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocolLaura Diab Casares, Juan Espinosa Pereiro, María Teresa Tórtola Fernández, et al.
Pageof 37